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Background
Mechanisms involved in regulating metabolic reprogram-
ming in cancer cells are not fully understood. Acetylation
is emerging as a major regulator of mitochondrial metabo-
lism and may contribute to metabolic derangements that
occur in cancer cells. Sirtuin-3, (SIRT3), is the main mito-
chondrial deacetylase and it serves to maintain mitochon-
drial energy homeostasis by deacetylating and activating
mitochondrial proteins. Loss of SIRT3 leads to altered
cellular metabolism including reduced ATP production
and decreased fatty acid oxidation [1]. Remarkably,
reduced SIRT3 expression is associated with cancer in
patients and Sirt3 knockout mice [2]. However, the
mechanism of mitochondrial protein hyperacetylation and
the sub-sequent increased susceptibility to tumor forma-
tion remains unknown.
Methods
Stable cell lines expressing shScramble or shSIRT3 were
made by lentiviral transduction in HepG2 and 293T
cells. Metabolomic analysis of stable cell lines were done
by GC/MS and MS/MS. Glutamine oxidation was mea-
sured by treating cells with 14C glutamine and captur-
ing radiolabeled CO2.
Results
Protein acetylation is particularly sensitive to nutrient sta-
tus, such as high fat diet feeding [3]. Our data show that
under the stress of a high fat diet, Sirt3 KO mice are sig-
nificantly more susceptible to the development of sponta-
neous hepatocellular carcinoma (92% penetrance) than
wild type mice (26% penetrance) after 12 months. Here we
show metabolomics data that suggests that SIRT3 in
HepG2 cells increased glutamine metabolism indicated by
lower relative glutamine levels, and altered alpha-ketoglu-
tarate levels. In support of this we find that SIRT3
knockdown cells have increased glutamine oxidation,
a characteristic metabolic change in cancer cells. Addition-
ally, these cells show increased expression of glucose
transporter, GLUT1, increased glucose uptake, and
elevated levels of citrate and other markers of increased
lipid synthesis.
Conclusions
These data illustrate an anabolic shift in cell metabolism
that is required to supply biosynthetic precursors neces-
sary for rapid cell growth. We believe that loss of SIRT3
and subsequent hyperacetylation of mitochondrial proteins
leads to a rerouting of energetic substrates supporting
oncogenically driven tumor growth.
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